PHARMA
Green Cross Expands Biologics To North America
The proposed US$163 million Green Cross facility will have the capacity to fractionate up to one million liters of plasma a year.
Lonza Singapore Receives GMP Certification
The GMP certification from the Singapore Health Science Authority allows Lonza to contract manufacture products for use in the United States and Europe.
Aegerion Conducts Phase III Trial For Anti-Cholesterol Drug
The clinical trial will test the efficacy of lomitapide as an adjunct treatment to reduce low-density lipoprotein cholesterol (LDL-C) in patients suffering from homozygous familial hypercholesterolemia.
University Of Queensland Spinoff Attracts US$45 Million
Spinifex Pharmaceuticals will use the investment to run clinical trials for EMA401, an oral treatment for pain that has been shown not to have central nervous system side effects.
Bayer Boosts Production Capacity In China
Bayer's US$139 million investment will make the Beijing site their largest pharmaceuticals packaging facility in China.
Sun Pharma Acquires Ranbaxy To Form India’s Largest Pharma
The US$3.2 billion transaction will form the largest pharmaceutical company in India and the fifth largest specialty generics manufacturer in the world.
Takeda Receives NDA Approval For Influenza Vaccine
Developed using cell culture-based technology, Takeda's H5N1 vaccine could help to strengthen Japan's pandemic preparedness.
RuiYi Raises US$15 Million And Expands Leadership Team
Chinese biotechnology company RuiYi, Inc. has raised US$15 million in Series B financing to develop their pipeline of monoclonal antibodies.
Golden Meditech Sells 27.9% Stake To Sanpower Group
Golden Meditech Holdings Ltd, a Chinese healthcare company, raised US$100 million via the sale of shares in Fortress Group Ltd to Sanpower Group.
